ym 529 has been researched along with novobiocin in 1 studies
Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (novobiocin) | Trials (novobiocin) | Recent Studies (post-2010) (novobiocin) |
---|---|---|---|---|---|
140 | 23 | 71 | 2,271 | 15 | 290 |
Protein | Taxonomy | ym 529 (IC50) | novobiocin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Mycolicibacterium smegmatis MC2 155 | 0.046 | |
DNA gyrase subunit B | Staphylococcus aureus | 0.0474 | |
DNA gyrase subunit B | Streptococcus pneumoniae TIGR4 | 0.037 | |
DNA gyrase subunit A | Escherichia coli K-12 | 0.1441 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.1537 | |
DNA topoisomerase 4 subunit B | Staphylococcus aureus | 7.9 | |
DNA gyrase subunit B | Mycolicibacterium smegmatis | 0.161 | |
DNA gyrase subunit A | Staphylococcus aureus | 0.0383 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 0.0446 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 0.1315 | |
DNA topoisomerase | Streptococcus pneumoniae | 2.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hall, P; Hudock, MP; Leon, A; Liu, L; Morita, CT; Oldfield, E; Puan, KJ; Studer, D; Yang, Y; Yin, F | 1 |
1 other study(ies) available for ym 529 and novobiocin
Article | Year |
---|---|
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Topics: Anti-Bacterial Agents; Cluster Analysis; Diphosphonates; Drug Synergism; Escherichia coli K12; Fosfomycin; Gene Expression; Geranyltranstransferase; Models, Molecular; Oligonucleotide Array Sequence Analysis; Quantitative Structure-Activity Relationship; Terpenes | 2006 |